20262151: Indivior Pharmaceuticals, Inc.; Supernus Pharmaceuticals, Inc.
HSR Early Termination Notices ·
20262151: Indivior Pharmaceuticals, Inc.; Supernus Pharmaceuticals, Inc. Date September 21, 2026 bjames@ftc.gov September 22, 2026 | 10:09AM Transaction Number 20262151 Acquiring Party Indivior Pharmaceuticals, Inc. Acquired Party Supernus Pharmaceuticals, Inc. Granting Status Granted Acquired Entities Supernus Pharmaceuticals, Inc.
20262151: Indivior Pharmaceuticals, Inc.; Supernus Pharmaceuticals, Inc. Date September 21, 2026 bjames@ftc.gov September 22, 2026 | 10:09AM Transaction Number 20262151 Acquiring Party Indivior Pharmaceuticals, Inc. Acquired Party Supernus Pharmaceuticals, Inc. Granting Status Granted Acquired Entities Supernus Pharmaceuticals, Inc.